Understanding Vitiligo: From Cosmetic Misconception to Autoimmune Reality

Welcome back to another Dermatology Times DermView series. In this episode titled "Understanding Vitiligo: From Cosmetic Misconception to Autoimmune Reality," moderator Nada Elbuluk, MD, MSc, FAAD discusses vitiligo with Susan Taylor, MD, FAAD.

Dr. Elbuluk opens the series by introducing the program's focus: examining vitiligo as a systemic autoimmune disease and exploring its pathogenesis, clinical presentation, psychological impacts, and the expanding role of JAK inhibitor therapy. She emphasizes that vitiligo has historically been mislabeled as a cosmetic condition, affecting approximately 1–2% of the global population — a figure representing millions of people.

Dr. Taylor underscores the importance of reframing vitiligo as a chronic and complex autoimmune disease. This shift changes the clinical approach, signaling the need for proactive evaluation, treatment, and monitoring, including screening for associated autoimmune conditions such as thyroid dysfunction. From the patient perspective, this reframing validates their experience, recognizing that vitiligo significantly impacts self-esteem and quality of life — and that effective therapies now exist.

Dr. Taylor notes that vitiligo affects individuals of all ages, races, genders, and ethnicities, although onset most commonly occurs before age 30. People with a personal or family history of autoimmune disorders are at higher risk. Notably, an estimated 40% of adults in the United States remain underdiagnosed. Dr. Elbuluk adds that while vitiligo occurs in all skin types, it is more visually apparent in skin of color due to the contrast between depigmented and unaffected skin.

The episode concludes with a discussion of how vitiligo presents clinically — primarily as non-segmental vitiligo with depigmented patches on the face, neck, scalp, and extremities — along with an introduction to the less common segmental form. Often-overlooked features include disease activity markers, difficult-to-treat areas such as mucous membranes and acral sites, and the profound impact on quality of life including anxiety, depression, and impaired self-esteem.

In the next episode, "Diagnosing Vitiligo: A Comprehensive Clinical and Laboratory Evaluation," the discussion turns to taking a thorough patient history, performing a complete physical exam, and ordering appropriate laboratory workup when evaluating a patient with vitiligo.